Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Goran Stojanovic, MD"'
Autor:
Zoran Andric, MD, Gabriella Gálffy, MD, Manuel Cobo Dols, MD, Barna Szima, MD, Goran Stojanovic, MD, Marina Petrovic, MD, Enriqueta Felip, MD, David Vicente Baz, MD, Santiago Ponce Aix, MD, Oscar Juan-Vidal, MD, Zsuzsanna Szalai, MD, Gyorgy Losonczy, MD, Antonio Calles Blanco, MD, Reyes Bernabe, MD, Gema García Ledo, MD, Andrés Aguilar Hernández, MD, Klaus Duecker, PhD, Dongli Zhou, PhD, Andreas Schroeder, MD, Guelseren Guezel, MD, Fortunato Ciardiello, MD, PhD
Publikováno v:
JTO Clinical and Research Reports, Vol 4, Iss 2, Pp 100461- (2023)
Introduction: We present the results of a phase 2a trial of first-line avelumab (anti–programmed death-ligand 1 antibody) plus cetuximab (anti–EGFR antibody) in patients with advanced squamous NSCLC. Methods: Patients with recurrent or metastatic
Externí odkaz:
https://doaj.org/article/283d0b24db6b460b8d6628f029ba7cc0
Autor:
Spigel DR; David R. Spigel, MD, Sarah Cannon Research Institute/Tennessee Oncology, Nashville, TN; Afshin Dowlati, MD, University Hospitals Seidman Cancer Center and Case Western Reserve University Cleveland, OH; Yuanbin Chen, MD, Cancer and Hematology Centers of Western Michigan, Grand Rapids, MI; Alejandro Navarro, MD, Hospital Universitario Vall d'Hebron and Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain; James Chih-Hsin Yang, MD, National Taiwan University Hospital and National Taiwan University Cancer Center, Taipei, Taiwan; Goran Stojanovic, MD, Institute for Pulmonary Diseases of Vojvodina, Sremska Kamenica, Serbia; Maria Jove, MD, PhD, Institut Català d'Oncologia Hospital Duran i Reynals, Barcelona, Spain; Patricia Rich, MD, Southeastern Regional Medical Center, Newnan, GA; Zoran G. Andric, MD, University Clinical Hospital Center Bezanijska Kosa, Belgrade, Serbia; Yi-Long Wu, MD, Guangdong Lung Cancer Institute, Guangzhou, China; Charles M. Rudin, MD PhD, Druckenmiller Center for Lung Cancer Research, Memorial Sloan Kettering Cancer Center, New York, NY; Huanyu Chen, PhD, Ipsen, Cambridge, MA; Li Zhang, MPH, Ipsen, Cambridge, MA; Stanley Yeung, PharmD, Ipsen, Cambridge, MA; Fawzi Benzaghou, MD, Ipsen, Cambridge, MA; Luis Paz-Ares, MD, Hospital Universitario 12 de Octubre, H120-CNIO Lung Cancer Unit, Universidad Complutense and Ciberonc, Madrid, Spain; and Paul A. Bunn, MD, University of Colorado School of Medicine, Aurora, CO., Dowlati A; David R. Spigel, MD, Sarah Cannon Research Institute/Tennessee Oncology, Nashville, TN; Afshin Dowlati, MD, University Hospitals Seidman Cancer Center and Case Western Reserve University Cleveland, OH; Yuanbin Chen, MD, Cancer and Hematology Centers of Western Michigan, Grand Rapids, MI; Alejandro Navarro, MD, Hospital Universitario Vall d'Hebron and Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain; James Chih-Hsin Yang, MD, National Taiwan University Hospital and National Taiwan University Cancer Center, Taipei, Taiwan; Goran Stojanovic, MD, Institute for Pulmonary Diseases of Vojvodina, Sremska Kamenica, Serbia; Maria Jove, MD, PhD, Institut Català d'Oncologia Hospital Duran i Reynals, Barcelona, Spain; Patricia Rich, MD, Southeastern Regional Medical Center, Newnan, GA; Zoran G. Andric, MD, University Clinical Hospital Center Bezanijska Kosa, Belgrade, Serbia; Yi-Long Wu, MD, Guangdong Lung Cancer Institute, Guangzhou, China; Charles M. Rudin, MD PhD, Druckenmiller Center for Lung Cancer Research, Memorial Sloan Kettering Cancer Center, New York, NY; Huanyu Chen, PhD, Ipsen, Cambridge, MA; Li Zhang, MPH, Ipsen, Cambridge, MA; Stanley Yeung, PharmD, Ipsen, Cambridge, MA; Fawzi Benzaghou, MD, Ipsen, Cambridge, MA; Luis Paz-Ares, MD, Hospital Universitario 12 de Octubre, H120-CNIO Lung Cancer Unit, Universidad Complutense and Ciberonc, Madrid, Spain; and Paul A. Bunn, MD, University of Colorado School of Medicine, Aurora, CO., Chen Y; David R. Spigel, MD, Sarah Cannon Research Institute/Tennessee Oncology, Nashville, TN; Afshin Dowlati, MD, University Hospitals Seidman Cancer Center and Case Western Reserve University Cleveland, OH; Yuanbin Chen, MD, Cancer and Hematology Centers of Western Michigan, Grand Rapids, MI; Alejandro Navarro, MD, Hospital Universitario Vall d'Hebron and Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain; James Chih-Hsin Yang, MD, National Taiwan University Hospital and National Taiwan University Cancer Center, Taipei, Taiwan; Goran Stojanovic, MD, Institute for Pulmonary Diseases of Vojvodina, Sremska Kamenica, Serbia; Maria Jove, MD, PhD, Institut Català d'Oncologia Hospital Duran i Reynals, Barcelona, Spain; Patricia Rich, MD, Southeastern Regional Medical Center, Newnan, GA; Zoran G. Andric, MD, University Clinical Hospital Center Bezanijska Kosa, Belgrade, Serbia; Yi-Long Wu, MD, Guangdong Lung Cancer Institute, Guangzhou, China; Charles M. Rudin, MD PhD, Druckenmiller Center for Lung Cancer Research, Memorial Sloan Kettering Cancer Center, New York, NY; Huanyu Chen, PhD, Ipsen, Cambridge, MA; Li Zhang, MPH, Ipsen, Cambridge, MA; Stanley Yeung, PharmD, Ipsen, Cambridge, MA; Fawzi Benzaghou, MD, Ipsen, Cambridge, MA; Luis Paz-Ares, MD, Hospital Universitario 12 de Octubre, H120-CNIO Lung Cancer Unit, Universidad Complutense and Ciberonc, Madrid, Spain; and Paul A. Bunn, MD, University of Colorado School of Medicine, Aurora, CO., Navarro A; David R. Spigel, MD, Sarah Cannon Research Institute/Tennessee Oncology, Nashville, TN; Afshin Dowlati, MD, University Hospitals Seidman Cancer Center and Case Western Reserve University Cleveland, OH; Yuanbin Chen, MD, Cancer and Hematology Centers of Western Michigan, Grand Rapids, MI; Alejandro Navarro, MD, Hospital Universitario Vall d'Hebron and Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain; James Chih-Hsin Yang, MD, National Taiwan University Hospital and National Taiwan University Cancer Center, Taipei, Taiwan; Goran Stojanovic, MD, Institute for Pulmonary Diseases of Vojvodina, Sremska Kamenica, Serbia; Maria Jove, MD, PhD, Institut Català d'Oncologia Hospital Duran i Reynals, Barcelona, Spain; Patricia Rich, MD, Southeastern Regional Medical Center, Newnan, GA; Zoran G. Andric, MD, University Clinical Hospital Center Bezanijska Kosa, Belgrade, Serbia; Yi-Long Wu, MD, Guangdong Lung Cancer Institute, Guangzhou, China; Charles M. Rudin, MD PhD, Druckenmiller Center for Lung Cancer Research, Memorial Sloan Kettering Cancer Center, New York, NY; Huanyu Chen, PhD, Ipsen, Cambridge, MA; Li Zhang, MPH, Ipsen, Cambridge, MA; Stanley Yeung, PharmD, Ipsen, Cambridge, MA; Fawzi Benzaghou, MD, Ipsen, Cambridge, MA; Luis Paz-Ares, MD, Hospital Universitario 12 de Octubre, H120-CNIO Lung Cancer Unit, Universidad Complutense and Ciberonc, Madrid, Spain; and Paul A. Bunn, MD, University of Colorado School of Medicine, Aurora, CO., Chih-Hsin Yang J; David R. Spigel, MD, Sarah Cannon Research Institute/Tennessee Oncology, Nashville, TN; Afshin Dowlati, MD, University Hospitals Seidman Cancer Center and Case Western Reserve University Cleveland, OH; Yuanbin Chen, MD, Cancer and Hematology Centers of Western Michigan, Grand Rapids, MI; Alejandro Navarro, MD, Hospital Universitario Vall d'Hebron and Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain; James Chih-Hsin Yang, MD, National Taiwan University Hospital and National Taiwan University Cancer Center, Taipei, Taiwan; Goran Stojanovic, MD, Institute for Pulmonary Diseases of Vojvodina, Sremska Kamenica, Serbia; Maria Jove, MD, PhD, Institut Català d'Oncologia Hospital Duran i Reynals, Barcelona, Spain; Patricia Rich, MD, Southeastern Regional Medical Center, Newnan, GA; Zoran G. Andric, MD, University Clinical Hospital Center Bezanijska Kosa, Belgrade, Serbia; Yi-Long Wu, MD, Guangdong Lung Cancer Institute, Guangzhou, China; Charles M. Rudin, MD PhD, Druckenmiller Center for Lung Cancer Research, Memorial Sloan Kettering Cancer Center, New York, NY; Huanyu Chen, PhD, Ipsen, Cambridge, MA; Li Zhang, MPH, Ipsen, Cambridge, MA; Stanley Yeung, PharmD, Ipsen, Cambridge, MA; Fawzi Benzaghou, MD, Ipsen, Cambridge, MA; Luis Paz-Ares, MD, Hospital Universitario 12 de Octubre, H120-CNIO Lung Cancer Unit, Universidad Complutense and Ciberonc, Madrid, Spain; and Paul A. Bunn, MD, University of Colorado School of Medicine, Aurora, CO., Stojanovic G; David R. Spigel, MD, Sarah Cannon Research Institute/Tennessee Oncology, Nashville, TN; Afshin Dowlati, MD, University Hospitals Seidman Cancer Center and Case Western Reserve University Cleveland, OH; Yuanbin Chen, MD, Cancer and Hematology Centers of Western Michigan, Grand Rapids, MI; Alejandro Navarro, MD, Hospital Universitario Vall d'Hebron and Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain; James Chih-Hsin Yang, MD, National Taiwan University Hospital and National Taiwan University Cancer Center, Taipei, Taiwan; Goran Stojanovic, MD, Institute for Pulmonary Diseases of Vojvodina, Sremska Kamenica, Serbia; Maria Jove, MD, PhD, Institut Català d'Oncologia Hospital Duran i Reynals, Barcelona, Spain; Patricia Rich, MD, Southeastern Regional Medical Center, Newnan, GA; Zoran G. Andric, MD, University Clinical Hospital Center Bezanijska Kosa, Belgrade, Serbia; Yi-Long Wu, MD, Guangdong Lung Cancer Institute, Guangzhou, China; Charles M. Rudin, MD PhD, Druckenmiller Center for Lung Cancer Research, Memorial Sloan Kettering Cancer Center, New York, NY; Huanyu Chen, PhD, Ipsen, Cambridge, MA; Li Zhang, MPH, Ipsen, Cambridge, MA; Stanley Yeung, PharmD, Ipsen, Cambridge, MA; Fawzi Benzaghou, MD, Ipsen, Cambridge, MA; Luis Paz-Ares, MD, Hospital Universitario 12 de Octubre, H120-CNIO Lung Cancer Unit, Universidad Complutense and Ciberonc, Madrid, Spain; and Paul A. Bunn, MD, University of Colorado School of Medicine, Aurora, CO., Jove M; David R. Spigel, MD, Sarah Cannon Research Institute/Tennessee Oncology, Nashville, TN; Afshin Dowlati, MD, University Hospitals Seidman Cancer Center and Case Western Reserve University Cleveland, OH; Yuanbin Chen, MD, Cancer and Hematology Centers of Western Michigan, Grand Rapids, MI; Alejandro Navarro, MD, Hospital Universitario Vall d'Hebron and Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain; James Chih-Hsin Yang, MD, National Taiwan University Hospital and National Taiwan University Cancer Center, Taipei, Taiwan; Goran Stojanovic, MD, Institute for Pulmonary Diseases of Vojvodina, Sremska Kamenica, Serbia; Maria Jove, MD, PhD, Institut Català d'Oncologia Hospital Duran i Reynals, Barcelona, Spain; Patricia Rich, MD, Southeastern Regional Medical Center, Newnan, GA; Zoran G. Andric, MD, University Clinical Hospital Center Bezanijska Kosa, Belgrade, Serbia; Yi-Long Wu, MD, Guangdong Lung Cancer Institute, Guangzhou, China; Charles M. Rudin, MD PhD, Druckenmiller Center for Lung Cancer Research, Memorial Sloan Kettering Cancer Center, New York, NY; Huanyu Chen, PhD, Ipsen, Cambridge, MA; Li Zhang, MPH, Ipsen, Cambridge, MA; Stanley Yeung, PharmD, Ipsen, Cambridge, MA; Fawzi Benzaghou, MD, Ipsen, Cambridge, MA; Luis Paz-Ares, MD, Hospital Universitario 12 de Octubre, H120-CNIO Lung Cancer Unit, Universidad Complutense and Ciberonc, Madrid, Spain; and Paul A. Bunn, MD, University of Colorado School of Medicine, Aurora, CO., Rich P; David R. Spigel, MD, Sarah Cannon Research Institute/Tennessee Oncology, Nashville, TN; Afshin Dowlati, MD, University Hospitals Seidman Cancer Center and Case Western Reserve University Cleveland, OH; Yuanbin Chen, MD, Cancer and Hematology Centers of Western Michigan, Grand Rapids, MI; Alejandro Navarro, MD, Hospital Universitario Vall d'Hebron and Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain; James Chih-Hsin Yang, MD, National Taiwan University Hospital and National Taiwan University Cancer Center, Taipei, Taiwan; Goran Stojanovic, MD, Institute for Pulmonary Diseases of Vojvodina, Sremska Kamenica, Serbia; Maria Jove, MD, PhD, Institut Català d'Oncologia Hospital Duran i Reynals, Barcelona, Spain; Patricia Rich, MD, Southeastern Regional Medical Center, Newnan, GA; Zoran G. Andric, MD, University Clinical Hospital Center Bezanijska Kosa, Belgrade, Serbia; Yi-Long Wu, MD, Guangdong Lung Cancer Institute, Guangzhou, China; Charles M. Rudin, MD PhD, Druckenmiller Center for Lung Cancer Research, Memorial Sloan Kettering Cancer Center, New York, NY; Huanyu Chen, PhD, Ipsen, Cambridge, MA; Li Zhang, MPH, Ipsen, Cambridge, MA; Stanley Yeung, PharmD, Ipsen, Cambridge, MA; Fawzi Benzaghou, MD, Ipsen, Cambridge, MA; Luis Paz-Ares, MD, Hospital Universitario 12 de Octubre, H120-CNIO Lung Cancer Unit, Universidad Complutense and Ciberonc, Madrid, Spain; and Paul A. Bunn, MD, University of Colorado School of Medicine, Aurora, CO., Andric ZG; David R. Spigel, MD, Sarah Cannon Research Institute/Tennessee Oncology, Nashville, TN; Afshin Dowlati, MD, University Hospitals Seidman Cancer Center and Case Western Reserve University Cleveland, OH; Yuanbin Chen, MD, Cancer and Hematology Centers of Western Michigan, Grand Rapids, MI; Alejandro Navarro, MD, Hospital Universitario Vall d'Hebron and Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain; James Chih-Hsin Yang, MD, National Taiwan University Hospital and National Taiwan University Cancer Center, Taipei, Taiwan; Goran Stojanovic, MD, Institute for Pulmonary Diseases of Vojvodina, Sremska Kamenica, Serbia; Maria Jove, MD, PhD, Institut Català d'Oncologia Hospital Duran i Reynals, Barcelona, Spain; Patricia Rich, MD, Southeastern Regional Medical Center, Newnan, GA; Zoran G. Andric, MD, University Clinical Hospital Center Bezanijska Kosa, Belgrade, Serbia; Yi-Long Wu, MD, Guangdong Lung Cancer Institute, Guangzhou, China; Charles M. Rudin, MD PhD, Druckenmiller Center for Lung Cancer Research, Memorial Sloan Kettering Cancer Center, New York, NY; Huanyu Chen, PhD, Ipsen, Cambridge, MA; Li Zhang, MPH, Ipsen, Cambridge, MA; Stanley Yeung, PharmD, Ipsen, Cambridge, MA; Fawzi Benzaghou, MD, Ipsen, Cambridge, MA; Luis Paz-Ares, MD, Hospital Universitario 12 de Octubre, H120-CNIO Lung Cancer Unit, Universidad Complutense and Ciberonc, Madrid, Spain; and Paul A. Bunn, MD, University of Colorado School of Medicine, Aurora, CO., Wu YL; David R. Spigel, MD, Sarah Cannon Research Institute/Tennessee Oncology, Nashville, TN; Afshin Dowlati, MD, University Hospitals Seidman Cancer Center and Case Western Reserve University Cleveland, OH; Yuanbin Chen, MD, Cancer and Hematology Centers of Western Michigan, Grand Rapids, MI; Alejandro Navarro, MD, Hospital Universitario Vall d'Hebron and Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain; James Chih-Hsin Yang, MD, National Taiwan University Hospital and National Taiwan University Cancer Center, Taipei, Taiwan; Goran Stojanovic, MD, Institute for Pulmonary Diseases of Vojvodina, Sremska Kamenica, Serbia; Maria Jove, MD, PhD, Institut Català d'Oncologia Hospital Duran i Reynals, Barcelona, Spain; Patricia Rich, MD, Southeastern Regional Medical Center, Newnan, GA; Zoran G. Andric, MD, University Clinical Hospital Center Bezanijska Kosa, Belgrade, Serbia; Yi-Long Wu, MD, Guangdong Lung Cancer Institute, Guangzhou, China; Charles M. Rudin, MD PhD, Druckenmiller Center for Lung Cancer Research, Memorial Sloan Kettering Cancer Center, New York, NY; Huanyu Chen, PhD, Ipsen, Cambridge, MA; Li Zhang, MPH, Ipsen, Cambridge, MA; Stanley Yeung, PharmD, Ipsen, Cambridge, MA; Fawzi Benzaghou, MD, Ipsen, Cambridge, MA; Luis Paz-Ares, MD, Hospital Universitario 12 de Octubre, H120-CNIO Lung Cancer Unit, Universidad Complutense and Ciberonc, Madrid, Spain; and Paul A. Bunn, MD, University of Colorado School of Medicine, Aurora, CO., Rudin CM; David R. Spigel, MD, Sarah Cannon Research Institute/Tennessee Oncology, Nashville, TN; Afshin Dowlati, MD, University Hospitals Seidman Cancer Center and Case Western Reserve University Cleveland, OH; Yuanbin Chen, MD, Cancer and Hematology Centers of Western Michigan, Grand Rapids, MI; Alejandro Navarro, MD, Hospital Universitario Vall d'Hebron and Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain; James Chih-Hsin Yang, MD, National Taiwan University Hospital and National Taiwan University Cancer Center, Taipei, Taiwan; Goran Stojanovic, MD, Institute for Pulmonary Diseases of Vojvodina, Sremska Kamenica, Serbia; Maria Jove, MD, PhD, Institut Català d'Oncologia Hospital Duran i Reynals, Barcelona, Spain; Patricia Rich, MD, Southeastern Regional Medical Center, Newnan, GA; Zoran G. Andric, MD, University Clinical Hospital Center Bezanijska Kosa, Belgrade, Serbia; Yi-Long Wu, MD, Guangdong Lung Cancer Institute, Guangzhou, China; Charles M. Rudin, MD PhD, Druckenmiller Center for Lung Cancer Research, Memorial Sloan Kettering Cancer Center, New York, NY; Huanyu Chen, PhD, Ipsen, Cambridge, MA; Li Zhang, MPH, Ipsen, Cambridge, MA; Stanley Yeung, PharmD, Ipsen, Cambridge, MA; Fawzi Benzaghou, MD, Ipsen, Cambridge, MA; Luis Paz-Ares, MD, Hospital Universitario 12 de Octubre, H120-CNIO Lung Cancer Unit, Universidad Complutense and Ciberonc, Madrid, Spain; and Paul A. Bunn, MD, University of Colorado School of Medicine, Aurora, CO., Chen H; David R. Spigel, MD, Sarah Cannon Research Institute/Tennessee Oncology, Nashville, TN; Afshin Dowlati, MD, University Hospitals Seidman Cancer Center and Case Western Reserve University Cleveland, OH; Yuanbin Chen, MD, Cancer and Hematology Centers of Western Michigan, Grand Rapids, MI; Alejandro Navarro, MD, Hospital Universitario Vall d'Hebron and Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain; James Chih-Hsin Yang, MD, National Taiwan University Hospital and National Taiwan University Cancer Center, Taipei, Taiwan; Goran Stojanovic, MD, Institute for Pulmonary Diseases of Vojvodina, Sremska Kamenica, Serbia; Maria Jove, MD, PhD, Institut Català d'Oncologia Hospital Duran i Reynals, Barcelona, Spain; Patricia Rich, MD, Southeastern Regional Medical Center, Newnan, GA; Zoran G. Andric, MD, University Clinical Hospital Center Bezanijska Kosa, Belgrade, Serbia; Yi-Long Wu, MD, Guangdong Lung Cancer Institute, Guangzhou, China; Charles M. Rudin, MD PhD, Druckenmiller Center for Lung Cancer Research, Memorial Sloan Kettering Cancer Center, New York, NY; Huanyu Chen, PhD, Ipsen, Cambridge, MA; Li Zhang, MPH, Ipsen, Cambridge, MA; Stanley Yeung, PharmD, Ipsen, Cambridge, MA; Fawzi Benzaghou, MD, Ipsen, Cambridge, MA; Luis Paz-Ares, MD, Hospital Universitario 12 de Octubre, H120-CNIO Lung Cancer Unit, Universidad Complutense and Ciberonc, Madrid, Spain; and Paul A. Bunn, MD, University of Colorado School of Medicine, Aurora, CO., Zhang L; David R. Spigel, MD, Sarah Cannon Research Institute/Tennessee Oncology, Nashville, TN; Afshin Dowlati, MD, University Hospitals Seidman Cancer Center and Case Western Reserve University Cleveland, OH; Yuanbin Chen, MD, Cancer and Hematology Centers of Western Michigan, Grand Rapids, MI; Alejandro Navarro, MD, Hospital Universitario Vall d'Hebron and Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain; James Chih-Hsin Yang, MD, National Taiwan University Hospital and National Taiwan University Cancer Center, Taipei, Taiwan; Goran Stojanovic, MD, Institute for Pulmonary Diseases of Vojvodina, Sremska Kamenica, Serbia; Maria Jove, MD, PhD, Institut Català d'Oncologia Hospital Duran i Reynals, Barcelona, Spain; Patricia Rich, MD, Southeastern Regional Medical Center, Newnan, GA; Zoran G. Andric, MD, University Clinical Hospital Center Bezanijska Kosa, Belgrade, Serbia; Yi-Long Wu, MD, Guangdong Lung Cancer Institute, Guangzhou, China; Charles M. Rudin, MD PhD, Druckenmiller Center for Lung Cancer Research, Memorial Sloan Kettering Cancer Center, New York, NY; Huanyu Chen, PhD, Ipsen, Cambridge, MA; Li Zhang, MPH, Ipsen, Cambridge, MA; Stanley Yeung, PharmD, Ipsen, Cambridge, MA; Fawzi Benzaghou, MD, Ipsen, Cambridge, MA; Luis Paz-Ares, MD, Hospital Universitario 12 de Octubre, H120-CNIO Lung Cancer Unit, Universidad Complutense and Ciberonc, Madrid, Spain; and Paul A. Bunn, MD, University of Colorado School of Medicine, Aurora, CO., Yeung S; David R. Spigel, MD, Sarah Cannon Research Institute/Tennessee Oncology, Nashville, TN; Afshin Dowlati, MD, University Hospitals Seidman Cancer Center and Case Western Reserve University Cleveland, OH; Yuanbin Chen, MD, Cancer and Hematology Centers of Western Michigan, Grand Rapids, MI; Alejandro Navarro, MD, Hospital Universitario Vall d'Hebron and Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain; James Chih-Hsin Yang, MD, National Taiwan University Hospital and National Taiwan University Cancer Center, Taipei, Taiwan; Goran Stojanovic, MD, Institute for Pulmonary Diseases of Vojvodina, Sremska Kamenica, Serbia; Maria Jove, MD, PhD, Institut Català d'Oncologia Hospital Duran i Reynals, Barcelona, Spain; Patricia Rich, MD, Southeastern Regional Medical Center, Newnan, GA; Zoran G. Andric, MD, University Clinical Hospital Center Bezanijska Kosa, Belgrade, Serbia; Yi-Long Wu, MD, Guangdong Lung Cancer Institute, Guangzhou, China; Charles M. Rudin, MD PhD, Druckenmiller Center for Lung Cancer Research, Memorial Sloan Kettering Cancer Center, New York, NY; Huanyu Chen, PhD, Ipsen, Cambridge, MA; Li Zhang, MPH, Ipsen, Cambridge, MA; Stanley Yeung, PharmD, Ipsen, Cambridge, MA; Fawzi Benzaghou, MD, Ipsen, Cambridge, MA; Luis Paz-Ares, MD, Hospital Universitario 12 de Octubre, H120-CNIO Lung Cancer Unit, Universidad Complutense and Ciberonc, Madrid, Spain; and Paul A. Bunn, MD, University of Colorado School of Medicine, Aurora, CO., Benzaghou F; David R. Spigel, MD, Sarah Cannon Research Institute/Tennessee Oncology, Nashville, TN; Afshin Dowlati, MD, University Hospitals Seidman Cancer Center and Case Western Reserve University Cleveland, OH; Yuanbin Chen, MD, Cancer and Hematology Centers of Western Michigan, Grand Rapids, MI; Alejandro Navarro, MD, Hospital Universitario Vall d'Hebron and Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain; James Chih-Hsin Yang, MD, National Taiwan University Hospital and National Taiwan University Cancer Center, Taipei, Taiwan; Goran Stojanovic, MD, Institute for Pulmonary Diseases of Vojvodina, Sremska Kamenica, Serbia; Maria Jove, MD, PhD, Institut Català d'Oncologia Hospital Duran i Reynals, Barcelona, Spain; Patricia Rich, MD, Southeastern Regional Medical Center, Newnan, GA; Zoran G. Andric, MD, University Clinical Hospital Center Bezanijska Kosa, Belgrade, Serbia; Yi-Long Wu, MD, Guangdong Lung Cancer Institute, Guangzhou, China; Charles M. Rudin, MD PhD, Druckenmiller Center for Lung Cancer Research, Memorial Sloan Kettering Cancer Center, New York, NY; Huanyu Chen, PhD, Ipsen, Cambridge, MA; Li Zhang, MPH, Ipsen, Cambridge, MA; Stanley Yeung, PharmD, Ipsen, Cambridge, MA; Fawzi Benzaghou, MD, Ipsen, Cambridge, MA; Luis Paz-Ares, MD, Hospital Universitario 12 de Octubre, H120-CNIO Lung Cancer Unit, Universidad Complutense and Ciberonc, Madrid, Spain; and Paul A. Bunn, MD, University of Colorado School of Medicine, Aurora, CO., Paz-Ares L; David R. Spigel, MD, Sarah Cannon Research Institute/Tennessee Oncology, Nashville, TN; Afshin Dowlati, MD, University Hospitals Seidman Cancer Center and Case Western Reserve University Cleveland, OH; Yuanbin Chen, MD, Cancer and Hematology Centers of Western Michigan, Grand Rapids, MI; Alejandro Navarro, MD, Hospital Universitario Vall d'Hebron and Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain; James Chih-Hsin Yang, MD, National Taiwan University Hospital and National Taiwan University Cancer Center, Taipei, Taiwan; Goran Stojanovic, MD, Institute for Pulmonary Diseases of Vojvodina, Sremska Kamenica, Serbia; Maria Jove, MD, PhD, Institut Català d'Oncologia Hospital Duran i Reynals, Barcelona, Spain; Patricia Rich, MD, Southeastern Regional Medical Center, Newnan, GA; Zoran G. Andric, MD, University Clinical Hospital Center Bezanijska Kosa, Belgrade, Serbia; Yi-Long Wu, MD, Guangdong Lung Cancer Institute, Guangzhou, China; Charles M. Rudin, MD PhD, Druckenmiller Center for Lung Cancer Research, Memorial Sloan Kettering Cancer Center, New York, NY; Huanyu Chen, PhD, Ipsen, Cambridge, MA; Li Zhang, MPH, Ipsen, Cambridge, MA; Stanley Yeung, PharmD, Ipsen, Cambridge, MA; Fawzi Benzaghou, MD, Ipsen, Cambridge, MA; Luis Paz-Ares, MD, Hospital Universitario 12 de Octubre, H120-CNIO Lung Cancer Unit, Universidad Complutense and Ciberonc, Madrid, Spain; and Paul A. Bunn, MD, University of Colorado School of Medicine, Aurora, CO., Bunn PA; David R. Spigel, MD, Sarah Cannon Research Institute/Tennessee Oncology, Nashville, TN; Afshin Dowlati, MD, University Hospitals Seidman Cancer Center and Case Western Reserve University Cleveland, OH; Yuanbin Chen, MD, Cancer and Hematology Centers of Western Michigan, Grand Rapids, MI; Alejandro Navarro, MD, Hospital Universitario Vall d'Hebron and Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain; James Chih-Hsin Yang, MD, National Taiwan University Hospital and National Taiwan University Cancer Center, Taipei, Taiwan; Goran Stojanovic, MD, Institute for Pulmonary Diseases of Vojvodina, Sremska Kamenica, Serbia; Maria Jove, MD, PhD, Institut Català d'Oncologia Hospital Duran i Reynals, Barcelona, Spain; Patricia Rich, MD, Southeastern Regional Medical Center, Newnan, GA; Zoran G. Andric, MD, University Clinical Hospital Center Bezanijska Kosa, Belgrade, Serbia; Yi-Long Wu, MD, Guangdong Lung Cancer Institute, Guangzhou, China; Charles M. Rudin, MD PhD, Druckenmiller Center for Lung Cancer Research, Memorial Sloan Kettering Cancer Center, New York, NY; Huanyu Chen, PhD, Ipsen, Cambridge, MA; Li Zhang, MPH, Ipsen, Cambridge, MA; Stanley Yeung, PharmD, Ipsen, Cambridge, MA; Fawzi Benzaghou, MD, Ipsen, Cambridge, MA; Luis Paz-Ares, MD, Hospital Universitario 12 de Octubre, H120-CNIO Lung Cancer Unit, Universidad Complutense and Ciberonc, Madrid, Spain; and Paul A. Bunn, MD, University of Colorado School of Medicine, Aurora, CO.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2024 Oct 09, pp. JCO2401374. Date of Electronic Publication: 2024 Oct 09.